Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

Colorectal cancer uses wound-healing processes to spread, suggesting new treatment targets.

Exercise may help reduce treatment side effects and improve survival in metastatic colorectal cancer.

The treatment is safe and shows promise for metastatic breast cancer.

Nephronectin is linked to worse outcomes in breast cancer and helps cancer spread.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Doxil's toxicity varies with dose and schedule, and pharmacokinetic guidance can optimize dosing.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Targeted therapies for advanced skin cancer often cause hair and nail problems, which need managing to avoid changing the treatment dose.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Axitinib treatment turned a man's grey hair back to black.

miR-325-3p can slow down brain tumor growth by targeting FOXM1.

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

The combination treatment showed a higher response rate but no significant survival benefits.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Using deep learning to predict gene expression from images could help assess colorectal cancer metastasis.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

Overexpression of PKCepsilon leads to increased TNFalpha, promoting metastatic squamous cell carcinoma in mice.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

A scalp-cooling system effectively prevents hair loss in breast cancer patients treated with eribulin.

Disodium folinate can safely and effectively replace calcium folinate in colorectal cancer treatment.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

The treatment combination is safe and effective for some patients with this type of breast cancer.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

RC48 shows promise for treating certain advanced cancers, but more research is needed.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Different types of skin cells have unique genetic markers that affect how likely they are to spread cancer.

Targeting the Smoothened receptor shows promise for treating certain cancers.